Anavex Life Sciences Corp (AVXL)

[crescentmotor]

That would justify the $30b+ some people think is possible.

Remember that there have been a couple of occasions when we saw big pharma increases in capitalization of $40 billion upon successful completions of AD Phase III trials before the commencement of sales revenue.